---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-21-000043"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T17:10:29.816153+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences appoints Jan De Witte as President and CEO, succeeding Peter Arduini

## Summary
- Jan De Witte to join prior to end of 2021; also appointed to board of directors.
- De Witte previously CEO of Barco N.V. and held senior roles at GE Healthcare IT.
- Compensation: $850k base salary, 110% target bonus, $2M initial RSU grant, severance provisions.
- Peter Arduini steps down as planned to become GE Healthcare CEO; no disagreement with Integra.
- De Witte brings 30-year healthcare/tech experience; appointment follows comprehensive CEO search.

## SEC filing metadata
- accession: 0000917520-21-000043
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/iart-20211028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-21-000043
- JSON: https://secwatch.observer/filing/0000917520-21-000043.json
- Plain text: https://secwatch.observer/filing/0000917520-21-000043.txt

## Key facts
- Executive change
  Jan D. De Witte was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: Director
  source text: the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm
- Executive change
  Jan D. De Witte was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On October 28, 2021, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.